MCF Advisors’s Anika Therapeutics ANIK Stock Holding History

MCF Advisors’s Portfolio ANIK Stock Details ANIK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-250	Closed	-$9K	–	463
2020 Q2	$9K	Hold	250	–	–	﹤0.01%	374
2020 Q1	$7K	Hold	250	–	–	﹤0.01%	384
2019 Q4	$13K	Hold	250	–	–	﹤0.01%	358
2019 Q3	$14K	Hold	250	–	–	﹤0.01%	345
2019 Q2	$10K	Hold	250	–	–	﹤0.01%	353
2019 Q1	$8K	Hold	250	–	–	﹤0.01%	357
2018 Q4	$8K	Hold	250	–	–	﹤0.01%	363
2018 Q3	$11K	Hold	250	–	–	﹤0.01%	349
2018 Q2	$8K	Hold	250	–	–	﹤0.01%	346
2018 Q1	$12K	Hold	250	–	–	﹤0.01%	316
2017 Q4	$13K	Hold	250	–	–	﹤0.01%	315
2017 Q3	$15K	Hold	250	–	–	﹤0.01%	317
2017 Q2	$12K	Hold	250	–	–	﹤0.01%	348
2017 Q1	$11K	Hold	250	–	–	﹤0.01%	346
2016 Q4	$12K	Hold	250	–	–	﹤0.01%	294
2016 Q3	$12K	Hold	250	–	–	﹤0.01%	305
2016 Q2	$13K	Hold	250	–	–	﹤0.01%	324
2016 Q1	$11K	Hold	250	–	–	﹤0.01%	308
2015 Q4	$10K	Hold	250	–	–	﹤0.01%	329
2015 Q3	$8K	Hold	250	–	–	﹤0.01%	341
2015 Q2	$8K	Hold	250	–	–	﹤0.01%	347
2015 Q1	$10K	Hold	250	–	–	﹤0.01%	323
2014 Q4	$10K	Hold	250	–	–	﹤0.01%	304
2014 Q3	$10K	Hold	250	–	–	﹤0.01%	312
2014 Q2	$10K	Hold	250	–	–	﹤0.01%	311
2014 Q1	$10K	Hold	250	–	–	﹤0.01%	313
2013 Q4	$10K	Hold	250	–	–	﹤0.01%	281
2013 Q3	$10K	Buy	+250	New	+$5.61K	0.01%	276

Other funds holding ANIK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return

MCF Advisors's ANIK Position: Q3 2020 in Review

MCF Advisors sold out of Anika Therapeutics (ANIK) in Q3 2020, closing a stake of 250 shares — an estimated $9K sold.

MCF Advisors first reported a position in ANIK in Q3 2013 and held it in 28 quarters. The position peaked at $15K in Q3 2017. 156 funds tracked by Wall St. Rank hold ANIK as of Q3 2020.

MCF Advisors reported no remaining Anika Therapeutics position as of Q3 2020 after selling out during the quarter.
MCF Advisors sold 250 Anika Therapeutics shares in Q3 2020, an estimated $9K.
MCF Advisors first reported a position in Anika Therapeutics in Q3 2013 and held it in 28 quarters.
MCF Advisors's Anika Therapeutics position peaked at $15K in Q3 2017.
156 funds tracked by Wall St. Rank held Anika Therapeutics as of Q3 2020.

Based on MCF Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.